Indomethacin in canine acute hemorrhagic pancreatitis.
The effects of indomethacin administration on hemodynamics were investigated in canine acute hemorrhagic pancreatitis (AHP). Thirteen mongrel dogs were randomly divided into a fluid treatment group, an indomethacin prophylaxis group (IMP), and an indomethacin therapy (IM) group. Indomethacin (5 mg/kg) was administered as a bolus dosage 30 min before the induction of AHP in the IMP group. In the IM group, indomethacin was also given as a bolus (5 mg/kg) in 5 min starting 30 min after the induction of AHP. AHP was induced with a mixture of trypsin and sodium taurocholate infused into the pancreatic duct. Hemodynamics were monitored during the 4.5 h of surveillance time. Heart rate did not change significantly between the groups. Indomethacin prophylaxis maintained mean arterial pressure at a significantly higher level (P less than 0.05) and prevented the initial fall in blood pressure when compared to the fluid treatment or IM group. Indomethacin increased cardiac output (P less than 0.05) in the IM group, but did not differ significantly in the IMP group in comparison with the fluid treatment group. In conclusion, the inhibition of the initial fall in blood pressure by indomethacin in AHP suggests prostaglandins to play a role in hemodynamic changes and pancreatic shock to be "septic" as evaluated by hemodynamic changes.
Kiviniemi
H
H
Dept. of Surgery, University of Oulu Central Hospital, Finland.
Rämö
O J
OJ
Ståhlberg
M
M
Kairaluoma
M I
MI
D000208:Acute Disease; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D006470:Hemorrhage / Q000503:physiopathology*; D007213:Indomethacin / Q000008:administration & dosage / Q000494:pharmacology*; D010195:Pancreatitis / Q000503:physiopathology*; D011453:Prostaglandins / Q000502:physiology; D012772:Shock, Septic / Q000503:physiopathology
D011453:Prostaglandins; D007213:Indomethacin